COVID-19

For details regarding directives for the 2020 Fall semester, please see:
 

Launching our 2021 photo contest 

This year, we want to see photos of how you’ve adapted to the challenges of conducting cancer-research during the pandemic. Winners may have their pieces of art immortalized in the centre’s corridors and publicized for promotional material.

The deadline to apply is February 28th.

Read more

GCRC wins big in new ‘Omics’ cancer competition

Two GCRC research teams have been selected as this year’s recipients of the newly launched “Omics Data Against Cancer” competition organized jointly by Génome Québec, Oncopole and IVADO.

Read more

New technique may lead to early and improved cancer detection

A team of GCRC researchers alongside McGill's Department of Chemical Engineering have found tiny and previously undetectable ‘hot spots’ of extremely high stiffness inside aggressive and invasive breast cancer tumours. 

Read more

GCRC & Friends:

a COVID-19 webinar 

Dr. Terry Hébert joined our Associate Director Dr. Thomas Duchaine to present an overview of strategies and principles of treatment against COVID-19. Watch the webinar.

State-of-the-art technology for cancer research

Located at the heart of McGill University’s Life Sciences Complex, we are a research and training facility that has attracted leading scientists from across the world.

Our collaborative approach is central to who we are 

Our investigators are tackling the most important problems in cancer research through innovative thinking and collaboration. Read a recent publication from one of our current PhD students.

Laying the groundwork for new therapies

By deepening our understanding of the mechanisms behind cancer, we are providing the core knowledge with clinicians to develop new cancer treatments.

Goodman Cancer Research Centre


The Goodman Cancer Research Centre is a recognized world-class research centre, contributing to innovative developments in the treatment and ultimately the cure for cancer. This state of the art Centre has energized cancer research at McGill, attracting internationally–renown investigators. These are exciting times, with an unprecedented collaboration between clinicians and basic scientists with the shared goal of investigating the nature of cancer and metastatic disease; working together to innovate, discover and develop new treatments for cancer patients.
 

Celebrating Success

Congratulations to Dr. Nahum Sonenberg for being awarded an honorary doctorate from the Institut national de la recherche scientifique (INRS).

Read the article.  

 

Faculty Spotlight

Dr. Alain Nepveu's lab investigates how alterations in DNA repair and DNA damage responses contribute to the initiation and progression of cancer.

Learn more

 

 

Latest Publication

Dr. Luke McCaffrey and Dr. Christopher Moraes & their research teams published a paper in Nature Communications which highlights a new technique that may lead to early and improved cancer detection.

Read the study

Learn about our COVID-19 response below:

Cancer Centre Tweets

News

29 Jun 2020

The GCRC wishes to acknowledge and recognize the immense commitment of Ms. Kappy Flanders, a friend of the GCRC and a great advocate, educator, philanthropist and social activist. 

25 Jun 2020

This article was taken from a special feature in Nature Metabolism where Dr Lawrence Kazak reflects on the journey that led him to become a researcher.

22 Jun 2020
GCRC researcher puts the spotlight on sex differences in melanoma
18 Jun 2020

Our lives changed this year in March when world leaders informed us we were facing a global pandemic.

17 Jun 2020

Although the Défi Canderel was cancelled this year due to COVID-19, the GCRC is organizing its own virtual run on the 11th July! We're asking people to do a 2K run, walk, jog or cycle in their local neighborhood wearing, if possible, their old déf

17 Jun 2020

PhD candidate Paul Savage from the Park Lab recently published a paper in Communications Biology on chemogenic profiling of breast cancer which revealed targetable vulnerabilities for difficult-to-treat tumours. 

Pages

Back to top